Suppr超能文献

利用68至102岁老年人尿白蛋白排泄量进行心血管疾病和死亡风险预测及分层:心血管健康研究

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study.

作者信息

Cao Jie J, Biggs Mary L, Barzilay Joshua, Konen Joseph, Psaty Bruce M, Kuller Lewis, Bleyer Anthony J, Olson Jean, Wexler Jason, Summerson John, Cushman Mary

机构信息

Research Department, St Francis Hospital, Division of Cardiology, Stony Brook University, SUNY, 100 Port Washington Boulevard, Roslyn, NY 11576, United States.

出版信息

Atherosclerosis. 2008 Apr;197(2):806-13. doi: 10.1016/j.atherosclerosis.2007.07.029. Epub 2007 Sep 17.

Abstract

BACKGROUND

Elevated urinary albumin excretion (UAE) is associated with the risk of cardiovascular disease (CVD) and all-cause mortality. We tested the hypothesis that elevated UAE improves cardiovascular risk stratification in an elderly cohort aged 68-102 years.

METHODS

We evaluated UAE in 3112 participants of the Cardiovascular Health Study who attended the 1996-1997 examination and had median follow up of 5.4 years. Elevated UAE was defined as urinary albumin to creatinine ratio > or =30 microg/mg. Microalbuminuria and macroalbuminuria were defined as urinary albumin to creatinine ratio 30-300 microg/mg and >300 microg/mg, respectively. Outcomes included CVD (myocardial infarction, stroke, cardiovascular death) and all-cause mortality. Cox proportional hazards models were used to assess the risk of outcomes associated with elevated UAE.

RESULTS

The prevalence of elevated UAE was 14.3%, 17.1% and 26.9% in those aged 68-74, 75-84 and 85-102 years, respectively. CVD incidence and all-cause mortality were doubled (7.2% and 8.1% per year) in those with microalbuminuria and tripled (11.1% and 12.3% per year) in those with macroalbuminuria compared to those with normal UAE (3.3% and 3.8% per year). The increased CVD and mortality risks were observed in all age groups after adjustment for conventional risk factors. The adjusted population attributable risk percent of CVD and all-cause mortality for elevated UAE was 11% and 12%, respectively. When participants were cross-classified by UAE and Framingham Risk Score categories, the 5-year cumulative incidence of coronary heart disease among participants with elevated UAE and a 5-year predicted risk of 5-10% was 20%, substantially higher than 6.3% in those with UAE <30m microg/mg.

CONCLUSION

Elevated UAE was associated with an increased risk of CVD and all-cause mortality in all age groups from 68 to 102 years. Combining elevated UAE with the Framingham risk scores may improve risk stratification for CVD in the elderly.

摘要

背景

尿白蛋白排泄量(UAE)升高与心血管疾病(CVD)风险及全因死亡率相关。我们检验了这样一个假设:在68至102岁的老年队列中,UAE升高可改善心血管风险分层。

方法

我们对心血管健康研究中3112名参与者的UAE进行了评估,这些参与者参加了1996 - 1997年的检查,中位随访时间为5.4年。UAE升高定义为尿白蛋白与肌酐比值≥30微克/毫克。微量白蛋白尿和大量白蛋白尿分别定义为尿白蛋白与肌酐比值为30 - 300微克/毫克和>300微克/毫克。结局包括CVD(心肌梗死、中风、心血管死亡)和全因死亡率。采用Cox比例风险模型评估与UAE升高相关的结局风险。

结果

在68 - 74岁、75 - 84岁和85 - 102岁的人群中,UAE升高的患病率分别为14.3%、17.1%和26.9%。与UAE正常者(每年3.3%和3.8%)相比,微量白蛋白尿者的CVD发病率和全因死亡率增加了一倍(每年7.2%和8.1%),大量白蛋白尿者则增加了两倍(每年11.1%和12.3%)。在对传统风险因素进行调整后,所有年龄组均观察到CVD和死亡风险增加。UAE升高导致的CVD和全因死亡率的调整后人群归因风险百分比分别为11%和12%。当参与者按UAE和弗明汉风险评分类别进行交叉分类时,UAE升高且5年预测风险为5 - 10%的参与者中冠心病的5年累积发病率为20%,显著高于UAE<30微克/毫克者的6.3%。

结论

在68至102岁的所有年龄组中,UAE升高与CVD风险及全因死亡率增加相关。将UAE升高与弗明汉风险评分相结合可能会改善老年人CVD的风险分层。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验